The relationship between tobacco use, substance-use disorders and mental health: Results from the National Survey of Mental Health and Well-being

Nicotine and Tobacco Research

Volumn 3, Issue 3, 2001, Pages 225-234

  Degenhardt, L ^a   Hall, W ^a  

^a UNIVERSITY OF NEW SOUTH WALES   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ALCOHOL; CANNABIS;

ADULT; AFFECTIVE NEUROSIS; AGED; ALCOHOL ABUSE; ANXIETY; ARTICLE; AUSTRALIA; CANNABIS ADDICTION; COMORBIDITY; CONTROLLED STUDY; DATA ANALYSIS; DEMOGRAPHY; DISABILITY; DISEASE CLASSIFICATION; DISTRESS SYNDROME; DRUG USE; FEMALE; HEALTH SURVEY; HUMAN; MALE; MEDICAL RESEARCH; MENTAL DISEASE; MENTAL HEALTH; MULTIVARIATE ANALYSIS; NEUROSIS; POPULATION; PRIORITY JOURNAL; PROBABILITY; PSYCHOSIS; SCORING SYSTEM; SMOKING; SMOKING CESSATION; SUBSTANCE ABUSE; TOBACCO; TOBACCO DEPENDENCE; WELLBEING;

EID: 0034851844     PISSN: 14622203     EISSN: None     Source Type: Journal    
DOI: 10.1080/14622200110050457     Document Type: Article

References (68)

1. Depression and the dynamics of smoking
2. The psychometric properties of the Composite International Diagnostic Interview
3. Comparative epidemiology of dependence on tobacco, alcohol, controlled substances, and inhalants: Basic findings from the National Comorbidity Survey
4. 1998 National Drug Strategy Household Survey: First results
5. Limitations of the application of fourfold table analysis to hospital data
6. Epidemiology of psychiatric disorders in Edmonton, Canada
7. Safety and efficacy of a smoking cessation program for recovering alcoholics
8. Effect of smoking cessation counseling on recovery from alcoholism: Findings from a randomized community intervention trial
9. Development of major depressive disorder during smoking cessation treatment
10. Nicotine dependence, major depression, and anxiety in young adults
11. Vulnerability to psychopathology in nicotine-dependent smokers: An epidemiologic study of young adults
12. DSM-III-R nicotine dependence in young adults: Prevalence, correlates and associated psychiatric disorders
13. Comorbidity in child psychopathology: Concepts, issues and research strategies
14. The CIDI-core substance abuse and dependence questions: Cross-cultural and nosological issues. The WHO/ ADAMHA Field Trial
15. Tobacco cessation among patients with depression
16. Nicotine dependence in schizophrenia: Clinical phenomena and laboratory findings
17. Alcoholism and smoking
18. Differential prevalence of cigarette smoking in patients with schizophrenic vs mood disorders
19. A comparison between the Present State Examination and the Composite International Diagnostic Interview
20. Substance misuse and psychiatric comorbidity: An overview of the OPCS National Psychiatric Morbidity Survey
21. Patterns of current and lifetime substance use in schizophrenia
22. Psychiatric comorbidity and treatment seeking: Sources of selection bias in the study of clinical populations
23. Personality, psychopathology and nicotine response as mediators of the genetics of smoking
24. Blue mood, blackened lungs: Depression and smoking
25. Cigarette smoking: Implications for psychiatric illness
26. Smoking, smoking cessation, and major depression
27. Heavy smokers, smoking cessation, and clonidine: Results of a double-randomized trial
28. Cigarette smoking in schizophrenia: Relationship to psychopathology and medication side effects
29. A User's Guide to the General Health Questionnaire
30. Nicotinic receptor desensitization and sensory gating deficits in schizophrenia
31. Caffeine and nicotine use in an addicted population
32. Involvement of tobacco in alcoholism and illicit drug use
33. Prevalence of smoking among psychiatric outpatients
34. Anxiolytics and anti-depressants for smoking cessation (Cochrane review)
35. Nicotine dependence treatment during inpatient treatment for other addictions: A prospective intervention trial
36. A comparison of sustained-release bupropion and placebo for smoking cessation
37. Psychotic disorders in urban areas: An overview of the Study on Low Prevalence disorders
38. Clinical observation of assessment using the Composite International Diagnostic Interview (CIDI): An analysis of the CIDI field trials - Wave II at the St Louis site
39. A controlled trial of sustained-release bupropion, a nicotine patch, or both for smoking cessation
40. Association between smoking and mental disorders: Results from an Australian National Prevalence Survey
41. Prevalence and demographic correlates of symptoms of last year dependence on alcohol, nicotine, marijuana and cocaine in the U.S. population
42. Adult sequelae of adolescent depressive symptoms
43. The consequences in young adulthood of adolescent drug involvement
44. Smoking and major depression: A causal analysis
45. A population-based twin study in women of smoking initiation and nicotine dependence
46. Kessler's 10 Psychological Distress Scale
47. Nicotine withdrawal in women
48. Nicotine dependence and withdrawal in alcoholic and nonalcoholic ever-smokers
49. Smoking and malignancy in schizophrenia
50. Smoking in first-episode patients with schizophrenia
51. Tobacco cessation with patients recovering from alcohol and other substance abuse
52. Addictive behaviors among hospitalised psychiatric patients
53. Depression, anxiety and smoking initiation: A prospective study over three years
54. Smoking in patients with panic disorder
55. Co-factors for smoking and evolutionary psychobiology
56. Psychiatric Disorders in America: The Epidemiological Catchment Area Study
57. When to begin smoking cessation in substance abusers
58. Alcohol, tobacco and cannabis: 12-year longitudinal associations with antecedent social context and personality
59. Meta-analysis on efficacy of nicotine replacement therapies in smoking cessation
60. Alcohol abuse and smoking
61. A 12-Item Short-Form Health Survey: Construction of scales and preliminary tests of reliability and validity
62. Prevalence and correlates of drug use and dependence in the United States
63. Socioeconomic distribution of smoking in a population of 10 529 New Zealanders
64. Cross-cultural feasibility, reliability and sources of variance of the Composite International Diagnostic Interview (CIDI. The Multicentre WHO/ADAMHA Field Trials